You are here: Industry Insights > COVID-19

News List

Scientists uncover SARS-CoV-2-specific T cell immunity in recovered COVID-19 and SARS patients worldpharmanews
July 17, 2020
The study by scientists from Duke-NUS Medical School, in close collaboration with the National University of Singapore (NUS) Yong Loo Lin School of Medicine, Singapore General Hospital (SGH) and National Centre for Infectious Diseases (NCID) was ...
Novartis offers non-profit medicines portfolio for Covid-19 pharmaceutical-technology
July 17, 2020
Swiss pharmaceutical giant Novartis has launched a not-for-profit medicines portfolio to help treat Covid-19 symptoms in patients in low-income and lower-middle-income countries.
US researchers say heparin may neutralise Covid-19 virus pharmaceutical-technology
July 17, 2020
Researchers at Rensselaer Polytechnic Institute in the US have said that the commonly available, US Food and Drug Administration (FDA)-approved drug heparin could effectively neutralise SARS-CoV-2, the virus that causes Covid-19.
IQVIA Partners with AstraZeneca contractpharma
July 17, 2020
?IQVIA has announced a collaboration with AstraZeneca to accelerate development of a potential new vaccine for COVID-19.
Catalent, Humanigen Expand Lenzilumab Services Pact contractpharma
July 17, 2020
Catalent will provide development, manufacturing and commercialization services for Humanigen’s GM-CSF monoclonal antibody being studied in COVID-19.
Novartis Launches Portfolio of Meds for COVID-19 Treatment contractpharma
July 17, 2020
Portfolio of 15 generic and OTC medicines from Sandoz will be sold at zero-profit to governments in eligible countries during the pandemic.
OSE Immunotherapeutics Receives Grant to Advance COVID-19 Vax contractpharma
July 17, 2020
OSE’s research program aims to develop a prophylactic vaccine focused on memory T cells and based on a multiepitope-peptide approach.
US FDA working to restart on-site inspections during week of July 20 expresspharma
July 17, 2020
The FDA, which is working towards resuming on-site inspections around July 20, also determined that, for the foreseeable future, prioritized domestic inspections will be pre-announced to FDA-regulated businesses.
Greater global cooperation needed to tackle vaccine-preventable diseases in a world with COVID-19 expresspharma
July 17, 2020
The authors of the study also included researchers at the University of Ghana, Imperial College London, the Center for Global Development Europe, London School of Hygiene & Tropical Medicine and the University of Cambridge.
World’s first phase III clinical trial of COVID-19 inactivated vaccine begins in UAE expresspharma
July 17, 2020
H.E. Sheikh Abdullah bin Mohammed Al Hamed, Chairman of Department of Health, Abu Dhabi is the first to participate in the vaccination trial.